Published: Mar 9, 2014 | Updated: Mar 9, 2014
Blood biomarkers in cognitively normal seniors were associated with their 3-year risk of developing mild cognitive impairment or Alzheimer's disease, researchers said, although the accuracy fell short of what would normally be acceptable for a screening test.
Read more: CLICK HERE
No comments:
Post a Comment